tapinarof 10 MG/ML Topical Cream [Vtama]
tapinarof
RxCUI: 2602306
What the CMS Formulary Data Shows for tapinarof 10 MG/ML Topical Cream [Vtama]
Per the CMS 2026 Part D formulary file, tapinarof 10 MG/ML Topical Cream [Vtama] (RxNorm concept RXCUI 2602306, generic name tapinarof) appears on 5 distinct formulary files spanning 131 Medicare Part D plan offerings - 2.6% of enrollable Part D products, selective placement; verify formulary inclusion before enrolling. Tier placement ranges from Tier 2 to Tier 5, with a cross-plan average of Tier 4.
Real-world access to tapinarof 10 MG/ML Topical Cream [Vtama] depends on utilization management as much as tier placement: 40% of covering formularies require prior authorization. 40% require step therapy. 40% apply quantity limits.
Historical spending context from the CMS Medicare Part D Drug Spending Dashboard shows 6,158 Part D beneficiaries filled tapinarof 10 MG/ML Topical Cream [Vtama] in 2023, with total plan-and-beneficiary spending of $18,812,197 and an average per-beneficiary annual cost of $3,054.92. The plan-by-plan detail below lists exactly which PDP and MA-PD contracts carry tapinarof 10 MG/ML Topical Cream [Vtama] today.
Coverage Details
- Formularies covering
- 5
- Plans covering
- 131
- Coverage rate
- 2.6%
- Tier range
- Tier 2 – Tier 5
- Average tier
- Tier 4, Non-Preferred
Restrictions
- Prior authorization required
- 40% of formularies
- Step therapy required
- 40% of formularies
- Quantity limits
- 40% of formularies
2023 Medicare Spending
- Beneficiaries
- 6,158
- Total spending
- $18,812,197
- Avg per beneficiary
- $3,054.92
Tier Distribution Across Plans
Medicare Advantage Plans (MA-PD) Covering tapinarof 10 MG/ML Topical Cream [Vtama]
100 Medicare Advantage plans with Part D drug coverage include this drug.
Frequently Asked Questions
Is tapinarof 10 MG/ML Topical Cream [Vtama] covered by Medicare Part D?
Yes, tapinarof 10 MG/ML Topical Cream [Vtama] is covered by 131 Medicare Part D plans (2.6% of all Part D formularies).
What tier is tapinarof 10 MG/ML Topical Cream [Vtama] on Medicare Part D plans?
tapinarof 10 MG/ML Topical Cream [Vtama] averages Tier 4 across Part D plans, ranging from Tier 2 to Tier 5.
Does tapinarof 10 MG/ML Topical Cream [Vtama] require prior authorization?
40% of Part D formularies require prior authorization for tapinarof 10 MG/ML Topical Cream [Vtama]. Step therapy: 40%. Quantity limits: 40%.
How much does Medicare spend on tapinarof 10 MG/ML Topical Cream [Vtama]?
In 2023, total Medicare Part D spending on tapinarof 10 MG/ML Topical Cream [Vtama] was $18,812,197, covering 6,158 beneficiaries. The average spend per beneficiary was $3,054.92.
Read our methodology - how this data is sourced, computed, and verified.